Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-6-7
pubmed:abstractText
In this series of 32 adult-to-adult living related liver transplantations, we assessed the efficacy and safety of basiliximab in combination with a tacrolimus-based regimen. Basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), has been extensively evaluated as induction therapy for cadaveric liver transplant recipients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1106-8
pubmed:meshHeading
pubmed-meshheading:16757278-Adolescent, pubmed-meshheading:16757278-Adrenal Cortex Hormones, pubmed-meshheading:16757278-Adult, pubmed-meshheading:16757278-Aged, pubmed-meshheading:16757278-Antibodies, Monoclonal, pubmed-meshheading:16757278-Drug Administration Schedule, pubmed-meshheading:16757278-Drug Therapy, Combination, pubmed-meshheading:16757278-Family, pubmed-meshheading:16757278-Graft Survival, pubmed-meshheading:16757278-Humans, pubmed-meshheading:16757278-Immunosuppression, pubmed-meshheading:16757278-Immunosuppressive Agents, pubmed-meshheading:16757278-Liver Cirrhosis, pubmed-meshheading:16757278-Liver Transplantation, pubmed-meshheading:16757278-Living Donors, pubmed-meshheading:16757278-Middle Aged, pubmed-meshheading:16757278-Recombinant Fusion Proteins, pubmed-meshheading:16757278-Safety, pubmed-meshheading:16757278-Survival Analysis, pubmed-meshheading:16757278-Tacrolimus
pubmed:year
2006
pubmed:articleTitle
A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
pubmed:affiliation
Istituto Mediterraneo Trapianti e Terapie ad Atta Specializzazione (IsMeTT), Italy, Palermo. sgruttadauria@ismett.edu
pubmed:publicationType
Journal Article, Clinical Trial